Il-Yang Pharm. Co., Ltd.   Report issue

For profit Phase 1 Phase 3 Phase 4
Founded: Gyeonggi-do Korea, Republic of (1946)
Status: No NME R&D (1946)

Organization Overview

First Clinical Trial
2005
NCT01820143
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

IL-YANG Pharmaceutical.Co.,Ltd. | IL-YANG Pharmaceutical Co.LTD | IL-YANG Pharmaceutical. Co., LTD | Il-Yang Pharm. Co., Ltd.